144 related articles for article (PubMed ID: 38506263)
1.
Kubeil M; Neuber C; Starke M; Arndt C; Rodrigues Loureiro L; Hoffmann L; Feldmann A; Bachmann M; Pietzsch J; Comba P; Stephan H
Chemistry; 2024 Jun; 30(32):e202400366. PubMed ID: 38506263
[TBL] [Abstract][Full Text] [Related]
2. Hexadentate bispidine derivatives as versatile bifunctional chelate agents for copper(II) radioisotopes.
Juran S; Walther M; Stephan H; Bergmann R; Steinbach J; Kraus W; Emmerling F; Comba P
Bioconjug Chem; 2009 Feb; 20(2):347-59. PubMed ID: 19173600
[TBL] [Abstract][Full Text] [Related]
3. Improved Conjugation, 64-Cu Radiolabeling, in Vivo Stability, and Imaging Using Nonprotected Bifunctional Macrocyclic Ligands: Bis(Phosphinate) Cyclam (BPC) Chelators.
David T; Hlinová V; Kubíček V; Bergmann R; Striese F; Berndt N; Szöllősi D; Kovács T; Máthé D; Bachmann M; Pietzsch HJ; Hermann P
J Med Chem; 2018 Oct; 61(19):8774-8796. PubMed ID: 30180567
[TBL] [Abstract][Full Text] [Related]
4. Optimization of pentadentate bispidines as bifunctional chelators for 64Cu positron emission tomography (PET).
Comba P; Hunoldt S; Morgen M; Pietzsch J; Stephan H; Wadepohl H
Inorg Chem; 2013 Jul; 52(14):8131-43. PubMed ID: 23819880
[TBL] [Abstract][Full Text] [Related]
5. Bispidine dioxotetraaza macrocycles: a new class of bispidines for (64)Cu PET imaging.
Comba P; Kubeil M; Pietzsch J; Rudolf H; Stephan H; Zarschler K
Inorg Chem; 2014 Jul; 53(13):6698-707. PubMed ID: 24906110
[TBL] [Abstract][Full Text] [Related]
6. Radiolabeling and in vivo behavior of copper-64-labeled cross-bridged cyclam ligands.
Sun X; Wuest M; Weisman GR; Wong EH; Reed DP; Boswell CA; Motekaitis R; Martell AE; Welch MJ; Anderson CJ
J Med Chem; 2002 Jan; 45(2):469-77. PubMed ID: 11784151
[TBL] [Abstract][Full Text] [Related]
7. Bispidines for radiopharmaceuticals.
Comba P; Kerscher M; Rück K; Starke M
Dalton Trans; 2018 Jul; 47(28):9202-9220. PubMed ID: 29862405
[TBL] [Abstract][Full Text] [Related]
8. Versatile Bispidine-Based Bifunctional Chelators for
Singh G; Zarschler K; Hunoldt S; Martínez IIS; Ruehl CL; Matterna M; Bergmann R; Máthé D; Hegedüs N; Bachmann M; Comba P; Stephan H
Chemistry; 2020 Feb; 26(9):1989-2001. PubMed ID: 31755596
[TBL] [Abstract][Full Text] [Related]
9. Development of Novel PSMA Ligands for Imaging and Therapy with Copper Isotopes.
Carlos Dos Santos J; Beijer B; Bauder-Wüst U; Schäfer M; Leotta K; Eder M; Benešová M; Kleist C; Giesel F; Kratochwil C; Kopka K; Haberkorn U; Mier W
J Nucl Med; 2020 Jan; 61(1):70-79. PubMed ID: 31541034
[TBL] [Abstract][Full Text] [Related]
10. Radiochemical and radiopharmacological characterization of a
Gao F; Sihver W; Bergmann R; Walther M; Stephan H; Belter B; Neuber C; Haase-Kohn C; Bolzati C; Pietzsch J; Pietzsch HJ
J Labelled Comp Radiopharm; 2019 Jun; 62(8):495-509. PubMed ID: 30912594
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and radiopharmacological evaluation of ⁶⁴Cu-labeled bombesin analogs featuring a bis(2-pyridylmethyl)-1,4,7-triazacyclononane chelator.
Bergmann R; Ruffani A; Graham B; Spiccia L; Steinbach J; Pietzsch J; Stephan H
Eur J Med Chem; 2013; 70():434-46. PubMed ID: 24184988
[TBL] [Abstract][Full Text] [Related]
12. Hetero-bivalent agents targeting FAP and PSMA.
Boinapally S; Lisok A; Lofland G; Minn I; Yan Y; Jiang Z; Shin MJ; Merino VF; Zheng L; Brayton C; Pomper MG; Banerjee SR
Eur J Nucl Med Mol Imaging; 2022 Nov; 49(13):4369-4381. PubMed ID: 35965291
[TBL] [Abstract][Full Text] [Related]
13. Comparison of DOTA and NODAGA as chelators for (64)Cu-labeled immunoconjugates.
Ghosh SC; Pinkston KL; Robinson H; Harvey BR; Wilganowski N; Gore K; Sevick-Muraca EM; Azhdarinia A
Nucl Med Biol; 2015 Feb; 42(2):177-83. PubMed ID: 25457653
[TBL] [Abstract][Full Text] [Related]
14. The computation of lipophilicities of ⁶⁴Cu PET systems based on a novel approach for fluctuating charges.
Comba P; Martin B; Sanyal A; Stephan H
Dalton Trans; 2013 Aug; 42(31):11066-73. PubMed ID: 23799488
[TBL] [Abstract][Full Text] [Related]
15. Positron emission tomography (PET) imaging of neuroblastoma and melanoma with 64Cu-SarAr immunoconjugates.
Voss SD; Smith SV; DiBartolo N; McIntosh LJ; Cyr EM; Bonab AA; Dearling JL; Carter EA; Fischman AJ; Treves ST; Gillies SD; Sargeson AM; Huston JS; Packard AB
Proc Natl Acad Sci U S A; 2007 Oct; 104(44):17489-93. PubMed ID: 17954911
[TBL] [Abstract][Full Text] [Related]
16. Imaging cancer using PET--the effect of the bifunctional chelator on the biodistribution of a (64)Cu-labeled antibody.
Dearling JL; Voss SD; Dunning P; Snay E; Fahey F; Smith SV; Huston JS; Meares CF; Treves ST; Packard AB
Nucl Med Biol; 2011 Jan; 38(1):29-38. PubMed ID: 21220127
[TBL] [Abstract][Full Text] [Related]
17. Novel hexadentate and pentadentate chelators for ⁶⁴Cu-based targeted PET imaging.
Sin I; Kang CS; Bandara N; Sun X; Zhong Y; Rogers BE; Chong HS
Bioorg Med Chem; 2014 Apr; 22(8):2553-62. PubMed ID: 24657050
[TBL] [Abstract][Full Text] [Related]
18. Preclinical evaluation of a
Jadvar H; Chen K; Park R; Yap LP; Vorobyova I; Swenson S; Markland FS
Amino Acids; 2019 Nov; 51(10-12):1569-1575. PubMed ID: 31621030
[TBL] [Abstract][Full Text] [Related]
19. Pycup--a bifunctional, cage-like ligand for (64)Cu radiolabeling.
Boros E; Rybak-Akimova E; Holland JP; Rietz T; Rotile N; Blasi F; Day H; Latifi R; Caravan P
Mol Pharm; 2014 Feb; 11(2):617-29. PubMed ID: 24294970
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, Copper(II) Complexation, (64)Cu-Labeling, and Bioconjugation of a New Bis(2-pyridylmethyl) Derivative of 1,4,7-Triazacyclononane.
Gasser G; Tjioe L; Graham B; Belousoff MJ; Juran S; Walther M; Künstler JU; Bergmann R; Stephan H; Spiccia L
Bioconjug Chem; 2008 Mar; 19(3):719-30. PubMed ID: 18254581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
